Pliant Therapeutics Receives $45,000,000 Series A Financing Round

  • Feed Type
  • Date
    2/19/2016
  • Company Name
    Pliant Therapeutics
  • Mailing Address
    700 Saginaw Drive Redwood City, CA 94063 USA
  • Company Description
    Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases.
  • Website
    http://www.pliantrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Pliant’s product engine has the potential to address the needs of many patients by targeting fibrosis in a variety of organs and conditions, including the lungs (IPF), liver (NASH and cirrhosis), kidney (renal fibrosis), skin (scleroderma), heart (cardiac fibrosis) and the gastrointestinal tract (Crohn’s disease).
  • M&A Terms
  • Venture Investor
    Third Rock Ventures
  • Venture Investor
    Undisclosed